agilon health (NYSE:AGL) Stock Price Down 8% – Here’s Why

agilon health, inc. (NYSE:AGL) traded down 8% on Tuesday . The company traded as low as $3.20 and last traded at $3.22. 1,871,620 shares were traded during trading, a decline of 62% from the average session volume of 4,954,811 shares. The stock had previously closed at $3.50.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. Bank of America cut shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price for the company. in a research report on Wednesday, October 2nd. Benchmark reissued a “buy” rating and issued a $9.00 price objective on shares of agilon health in a research report on Thursday, August 8th. Evercore ISI reduced their target price on agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 8th. Royal Bank of Canada reiterated an “outperform” rating and issued a $8.00 price target on shares of agilon health in a research note on Wednesday, August 7th. Finally, Deutsche Bank Aktiengesellschaft dropped their price target on agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. Two research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $8.03.

agilon health Stock Up 1.1 %

The firm has a market cap of $1.36 billion, a PE ratio of -4.71 and a beta of 0.54. The business has a 50-day moving average price of $3.92 and a two-hundred day moving average price of $5.25. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.04.

agilon health (NYSE:AGL) last posted its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.07). agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The company had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter last year, the company earned ($0.04) EPS. agilon health’s revenue for the quarter was up 38.7% compared to the same quarter last year. On average, equities research analysts expect that agilon health, inc. will post -0.32 EPS for the current year.

Insiders Place Their Bets

In other news, CEO Steven Sell acquired 20,000 shares of the company’s stock in a transaction on Thursday, September 12th. The shares were bought at an average price of $3.36 per share, with a total value of $67,200.00. Following the completion of the acquisition, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 3.20% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On agilon health

A number of hedge funds have recently modified their holdings of AGL. Vanguard Group Inc. boosted its stake in agilon health by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after purchasing an additional 371,537 shares during the period. AQR Capital Management LLC increased its holdings in shares of agilon health by 3,338.5% in the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after purchasing an additional 1,316,990 shares during the period. Susquehanna Fundamental Investments LLC increased its holdings in shares of agilon health by 65.0% in the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock valued at $5,262,000 after purchasing an additional 316,856 shares during the period. Capital International Investors raised its stake in shares of agilon health by 84.7% during the first quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock worth $123,207,000 after purchasing an additional 9,263,296 shares during the last quarter. Finally, Simplicity Wealth LLC lifted its holdings in shares of agilon health by 145.1% during the second quarter. Simplicity Wealth LLC now owns 26,210 shares of the company’s stock worth $171,000 after purchasing an additional 15,515 shares during the period.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.